GoodRx Holdings, Inc. GDRX Other revenue — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s other revenue — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s other revenue — revenue?
- GoodRx Holdings, Inc. (GDRX) reported other revenue — revenue of $3.69M in Q1 2026.
- How has GoodRx Holdings, Inc.'s other revenue — revenue changed year-over-year?
- GoodRx Holdings, Inc.'s other revenue — revenue decreased by 15.8% year-over-year, from $4.38M to $3.69M.
- What is the long-term trend for GoodRx Holdings, Inc.'s other revenue — revenue?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s other revenue — revenue has grown at a -1.4% compound annual growth rate (CAGR), from $18.79M to $17.75M.
- What does other revenue — revenue mean?
- This metric represents revenue generated from ancillary business activities or secondary service offerings that fall outside of the company's primary prescription price comparison and pharmacy benefit manager-related operations. It captures diversified income streams that contribute to the overall digital healthcare platform ecosystem but are not core to the main transaction-based revenue model. Monitoring this segment helps investors assess the company's ability to monetize non-core assets and evaluate the scale of its secondary service portfolio.